Signaling Pathways - Insulin and Insulin-like Receptors - Quinone reductase - Sphingosine kinases (SphKs) - HMG-CoA Reductases
清除全部
- B1788 Mevastatin中文名: 美伐他汀Target: HMG-CoA ReductasesSummary: HMG-CoA还原酶抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8522 Simvastatin (Zocor)中文名: 辛伐他汀Target: HMG-CoA ReductasesSummary: HMGCR(HMG-CoA还原酶)抑制剂
- A8504 Pitavastatin Calcium1 Citation中文名: 匹伐他汀钙Target: HMG-CoA ReductasesSummary: 酶HMGCR抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂